Millennium Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-71,470
| Closed | -$182K | – | 6952 |
|
|
2023
Q1 | $182K | Sell |
71,470
-497,098
| -87% | -$982K | ﹤0.01% | 5211 |
|
|
2022
Q4 | $1.06M | Buy |
568,568
+274,469
| +93% | +$684K | ﹤0.01% | 4105 |
|
|
2022
Q3 | $756K | Sell |
294,099
-210,122
| -42% | -$523K | ﹤0.01% | 4579 |
|
|
2022
Q2 | $973K | Buy |
504,221
+346,050
| +219% | +$755K | ﹤0.01% | 4395 |
|
|
2022
Q1 | $470K | Buy |
+158,171
| New | +$595K | ﹤0.01% | 5171 |
|
|
2021
Q4 | – | Sell |
-22,313
| Closed | -$108K | – | 7580 |
|
|
2021
Q3 | $108K | Sell |
22,313
-227,472
| -91% | -$1.25M | ﹤0.01% | 6406 |
|
|
2021
Q2 | $1.7M | Buy |
+249,785
| New | +$2.02M | ﹤0.01% | 4150 |
|
|
2020
Q3 | – | Sell |
-11,627
| Closed | -$61K | – | 4934 |
|
|
2020
Q2 | $61K | Sell |
11,627
-4,948
| -30% | -$22K | ﹤0.01% | 4034 |
|
|
2020
Q1 | $52K | Sell |
16,575
-17,196
| -51% | -$63.4K | ﹤0.01% | 3663 |
|
|
2019
Q4 | $136K | Buy |
+33,771
| New | +$117K | ﹤0.01% | 3961 |
|
|
2019
Q2 | – | Sell |
-209,760
| Closed | -$1.12M | – | 4600 |
|
|
2019
Q1 | $1.12M | Buy |
+209,760
| New | +$1.35M | ﹤0.01% | 2792 |
|
|
2018
Q4 | – | Sell |
-14,281
| Closed | -$139K | – | 4304 |
|
|
2018
Q3 | $139K | Sell |
14,281
-101,207
| -88% | -$1.02M | ﹤0.01% | 3701 |
|
|
2018
Q2 | $1.18M | Buy |
115,488
+32,984
| +40% | +$373K | ﹤0.01% | 2734 |
|
|
2018
Q1 | $1.07M | Sell |
82,504
-213,118
| -72% | -$3.17M | ﹤0.01% | 2652 |
|
|
2017
Q4 | $5.29M | Sell |
295,622
-38,731
| -12% | -$808K | 0.01% | 1715 |
|
|
2017
Q3 | $8.39M | Buy |
334,353
+313,144
| +1,476% | +$7.29M | 0.01% | 1349 |
|
|
2017
Q2 | $511K | Sell |
21,209
-490,746
| -96% | -$10.8M | ﹤0.01% | 2795 |
|
|
2017
Q1 | $9.9M | Buy |
+511,955
| New | +$8.07M | 0.02% | 1036 |
|
|
2016
Q4 | – | Sell |
-41,617
| Closed | -$541K | – | 3846 |
|
|
2016
Q3 | $541K | Sell |
41,617
-129,612
| -76% | -$1.72M | ﹤0.01% | 2568 |
|
|
2016
Q2 | $2.38M | Buy |
+171,229
| New | +$2.52M | 0.01% | 1691 |
|
|
2015
Q3 | – | Sell |
-38,286
| Closed | -$987K | – | 3815 |
|
|
2015
Q2 | $987K | Buy |
38,286
+16,872
| +79% | +$479K | ﹤0.01% | 2292 |
|
|
2015
Q1 | $669K | Buy |
+21,414
| New | +$615K | ﹤0.01% | 2566 |
|
|
2013
Q3 | – | Sell |
-3,000
| Closed | -$109K | – | 3645 |
|
|
2013
Q2 | $109K | Buy |
+3,000
| New | +$129K | ﹤0.01% | 2861 |
|
Other funds holding PRTK
BC
NM
Millennium Management's PRTK Position: Q2 2023 in Review
Millennium Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 71,470 shares — an estimated $182K sold.
Millennium Management first reported a position in PRTK in Q2 2013 and held it in 23 quarters. The position peaked at $9.9M in Q1 2017. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.
- Millennium Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Millennium Management sold 71,470 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $182K.
- Millennium Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
- Millennium Management's Paratek Pharmaceuticals, Inc. position peaked at $9.9M in Q1 2017.
- 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.